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OBJECTIVE: Few studies have assessed the effect of erec-
tile dysfunction (ED) treatment for psychological adjust-
ment. This study assessed the impact of ED therapy 
on psychological functioning at baseline and 12-month
follow-up using a battery of 10 standard psychological
measures previously used in ED research. METHODS:
Using an observational ED disease registry, clinical,
sociodemographic psychological, and HRQoL informa-
tion was collected at baseline prior to treatment and at 3,
6 and 12 months later. Psychological measures included
the Beck Depression Inventory, a Life Satisfaction ques-
tion, Marital Happiness item from the Locke Wallace
Marital Adjustment Test, Mental Health Index 5, SF 36
Vitality scale, SOS 10 (a measure of general psychologi-
cal health), State Trait Anxiety measure, and three MOS
subscales (Positive Affect, Belonging/Loneliness, Marital
Functioning). Only men who reported undergoing ED
treatment were included in this analysis sub-sample.
Patients were classiﬁed as treatment responders based on
improvements in IIEF scores. Group means at baseline
and 12-months and change between timepoints were
compared using t-tests. RESULTS: The cohort consisted
of 89 patients. 40 (45%) responded to therapy by the IIEF
criteria. At one year, responders reported better psycho-
logical functioning on 7 measures, with differences being
signiﬁcant (p < .05) on Life Satisfaction, Marital Happi-
ness, Positive Affect, and SOS 10. Responders reported
signiﬁcant improvement (p < .05) from baseline on 3 mea-
sures (Life Satisfaction, Positive Affect, and SOS 10) and
a signiﬁcant decline on one (SF 36 Vitality). CONCLU-
SIONS: Diagnosing and successfully treating ED has a
signiﬁcant impact on patient psychological functioning.
These results should encourage providers to actively diag-
nose and treat ED. Data from this study show that men
who fail primary therapy for ED should be offered sec-
ondary treatment, as many men in this study who failed
prior therapies still reported improved psychological
functioning when they began an effective secondary 
treatment.
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OBJECTIVE: Response to erectile dysfunction (ED) treat-
ment has typically been reported over a three-month
period in a number of pharmaceutical trials. Little is
known about the factors associated with response to
treatment over a longer period. The current study exam-
ines predictors associated with response to treatment at
12 months in a group of men enrolled in an ED disease
registry study. METHODS: Clinical information was col-
lected at baseline and HRQOL data was collected at base-
line, 3, 6, and 12-months. Eighty-nine men reported
receiving ED treatment while enrolled in the study and
completed the 12-month HRQOL questionnaire. Scores
on the IIEF erectile functioning scale at baseline and 
12-months were compared. Men who reported a 4-point
or greater improvement were considered treatment
responders (N = 40). Forty-nine men were classiﬁed as
non-responders. A multivariate logistic regression model
predicting treatment response at 12 months and control-
ling for age and baseline erectile functioning was speci-
ﬁed. RESULTS: Men who were treatment responders at
the 12-month follow-up were signiﬁcantly more likely at
baseline to have a partner who encourages sex (OR =
4.230, p = .0369), be unmarried (OR = 0.05, p = .0020),
report greater rigidity during sex (OR = 4.814, p = .0288),
and have more frequent morning erections (OR = 4.360,
p = .0432). CONCLUSIONS: Long-term response to ED
treatment is signiﬁcantly associated with baseline erectile
functioning (as measured by frequency of morning erec-
tions and penile rigidity during sex) and the supportive-
ness of a partner. Practitioners can use this information
to guide patient expectations for treatment outcomes and
to recommend other treatment if relationship concerns
are present.
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OBJECTIVE: To evaluate the psychometric properties 
of a new disease speciﬁc instrument, the female sexual
desire proﬁle (FSDP). METHODS: The FSDP is a self-
assessment questionnaire containing eight items that
address the occurrence of sexual desire and sexual recep-
tivity. The study enrolled a total of 174 patients with
hypoactive sexual desire disorder in 5 countries (Canada,
UK, Poland, Hungary and The Netherlands) randomized
to receive either active treatment or placebo. Patients
completed the FSDP on a daily basis during the baseline
and treatment periods. Standard psychometric analyses
were conducted. RESULTS: Conﬁrmatory factor analysis
was undertaken to provide evidence of a single construct
of desire in the FSDP. All FSDP questions loaded onto the
factor in excess of 0.4. Three questions had high loadings
in excess of 0.7 (items 2, 4 and 5). The FSDP had good
internal consistency, 0.72 for the baseline data and 0.86
for the treatment period. There was no indication of item
redundancy. The FSDP scores showed a moderate corre-
lation with desire domain of the Female Sexual Function
Index (FSFI) for the baseline period (0.39) and treatment
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period (0.68). The FSDP was able to distinguish between
high and low scorers on the FSFI at baseline (p < 0.001).
CONCLUSIONS: The FSDP has shown good psychome-
tric properties and is an appropriate measure of quality
of life in this patient population. Further validation
studies are planned to evaluate this new instrument in
patients with female sexual desire disorder.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population
of men over 50 years of age. This is thus a public health
problem with a number of diagnostic, therapeutic and
economic facets. The severity of the problem is assessed
by the score obtained on the IPSS, a well-known and
recognised questionnaire. OBJECTIVE: As part of the
growing importance attached to the care giver, it is inter-
esting to evaluate the consequences of this masculine
pathology for the spouse. METHOD: As part of a cohort
study, the GP gave the patient 2 PFM (Patient Family
Measurement) self-questionnaires for himself and his
spouse. For the analysis, 357 patient questionnaires and
316 spouse questionnaires were used. The sexuality of the
patient was measured by the—IIEF-International Index of
Erectil Function. Spouses were asked about their Sexual
Desire—SD- and Overall Satisfaction—OS-. RESULTS:
For BPH patients, all the IIEF dimensions are deteriorated
according to the severity expressed by the IPSS score. This
is particularly true for the SD (52.8 – 46.6 – 35.2) and
OS (69.6 – 57.3 – 40.4) dimensions. For the spouses who
answered the questionnaires, the SD lack or the overall
dissatisfaction are directly correlated with the IIEF score
expressed by their partners for the corresponding dimen-
sions p < 0.005—Spouse Sexual Desire: Nil to Weak: IIEF
DS Dimension Score: 42.7—Medium to High: IIEF DS
Dimension Score: 76.0—Spouse Satisfaction: Dissatisﬁed:
IIEF OS Dimension Score: 46.1—Divided to Satisﬁed:
IIEF OS Dimension Score: 67.2. CONCLUSION: The
high spouse questionnaires’ response rate showed the
interest and involvement of spouses in their husband’s
disease. BPH patients sexuality is deteriorated according
to the pathology severity, spouses express this deteriora-
tion in the same way.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population
of men over 50 years of age. This is thus a public health
problem with a number of diagnostic, therapeutic and
economic facets. The severity of the problem is assessed
by the score obtained on the IPSS, a well-known and
recognised questionnaire. OBJECTIVE: As part of the
growing importance attached to the caregiver, it is inter-
esting to evaluate the consequences of this masculine
pathology for the spouse. METHOD: As part of a cohort
study, the GP gave the patient 2 PFM (Patient Family
Measurement) self-questionnaires for himself and his
spouse. For the analysis, 357 patient questionnaires and
316 spouse questionnaires were used. The rate of return
of the spouse questionnaires (88%) was very satisfactory.
The quality of life (QOL) of the patient was measured by
SF12; the results consisted of 2 scores: mental (MCS-12)
and physical (PCS-12). The norm observed in the Amer-
ican population, and from which the scores were stan-
dardised, was 50. In the patient where the QOL had
deteriorated, all the scores were lower than this norm,
(PCS-12 = 46 & MCS-12 = 47.2). This deterioration in
the quality of life also applied to the spouse. (PCS-12 =
44.4 & MCS-12 = 45.9). For the PCS-12, the difference
was signiﬁcant. CONCLUSION: The rate of return of the
spouse questionnaires showed the interest and involve-
ment of spouses in their husband’s pathology. The dete-
rioration in the quality of life of the spouse highlighted
the impact of the disease on those around him. In both
the patient and the spouse, the quality of life deteriorated
with the severity of the BPH.
